Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2023. Go to the latest filing (Q3 2026)

24.6B USDQ3 2023
Total value of stock positions
24.6B USD
Positions
79
Share of the ten largest
42.7%

The ten largest positions Q3 2023

  1. Visa Inc. 6.5%▼ −2.4%
  2. Workday, Inc. 4.6%▲ +72.3%
  3. Amazon 4.5%▲ +98.8%
  4. United Parcel Service 4.2%▲ +649.1%
  5. Danaher Corporation 4.2%▼ −3.4%
  6. Microsoft 3.9%▲ +151.6%
  7. UnitedHealth Group 3.8%▲ +3.5%
  8. Meta Platforms 3.7%▲ +17.8%
  9. Api Group Corp 3.6%unchanged
  10. GE Aerospace 3.6%▲ +12.0%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q3 2023

Positions Q3 2023 per 13F filing, 79 of 79
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 4.5% 8,749,993 1.1B USD +98.8% increased Q2 2015 34 quarters
MSFT Microsoft 3.9% 3,024,399 955.0M USD +151.6% increased Q2 2016 30 quarters
V Visa Inc. 6.5% 6,971,335 1.6B USD −2.4% reduced Q3 2016 29 quarters
Bridgebio Pharma Inc 2.7% 25,120,991 662.4M USD −5.6% reduced Q2 2019 18 quarters
Adaptive Biotechnologies Cor 0.7% 29,993,708 163.5M USD unchanged Q2 2019 18 quarters
FTV Fortive 2.5% 8,325,095 617.4M USD −15.0% reduced Q3 2019 17 quarters
Api Group Corp 3.6% 34,199,532 886.8M USD unchanged Q2 2020 14 quarters
TMO Thermo Fisher Scientific 1.9% 899,715 455.4M USD +8.0% increased Q2 2020 14 quarters
Royalty Pharma PLC 1.0% 9,464,201 256.9M USD −3.9% reduced Q2 2020 14 quarters
Karuna Therapeutics Inc 0.8% 1,131,263 191.3M USD +19.3% increased Q3 2020 13 quarters
Inhibrx Inc 0.5% 7,150,826 131.2M USD +7.7% increased Q3 2020 13 quarters
META Meta Platforms 3.7% 3,057,022 917.7M USD +17.8% increased Q4 2020 12 quarters
GE GE Aerospace 3.6% 7,996,906 884.1M USD +12.0% increased Q4 2020 12 quarters
Acadia Healthcare Company In 0.6% 2,255,213 158.6M USD −30.4% reduced Q4 2020 12 quarters
4D Molecular Therapeutics In 0.2% 4,787,914 61.0M USD unchanged Q4 2020 12 quarters
Kinnate Biopharma Inc < 0.1% 1,820,462 2.5M USD unchanged Q4 2020 12 quarters
AMP Ameriprise Financial 2.3% 1,734,018 571.7M USD +54.3% increased Q1 2021 11 quarters
Pharvaris N V 0.3% 3,231,923 67.5M USD unchanged Q1 2021 11 quarters
Zai Lab Ltd 0.2% 2,491,003 60.6M USD −5.3% reduced Q1 2021 11 quarters
Edgewise Therapeutics Inc 0.1% 6,159,146 35.3M USD +3.6% increased Q1 2021 11 quarters
Day One Biopharmaceuticals I 0.1% 2,558,563 31.4M USD unchanged Q2 2021 10 quarters
Hdfc Bank Ltd 2.4% 10,116,023 596.9M USD +8.6% increased Q3 2021 9 quarters
Ginkgo Bioworks Holdings Inc 1.1% 143,085,126 259.0M USD unchanged Q3 2021 9 quarters
Rallybio Corp < 0.1% 4,194,777 14.1M USD unchanged Q3 2021 9 quarters
Roivant Sciences Ltd 3.5% 73,434,301 857.7M USD −2.4% reduced Q4 2021 8 quarters
Biomarin Pharmaceutical Inc 1.5% 4,215,456 373.0M USD +1.4% increased Q4 2021 8 quarters
IFF International Flavors & Fragrances 0.6% 2,067,060 140.9M USD −42.1% reduced Q4 2021 8 quarters
Lianbio < 0.1% 3,564,173 5.3M USD unchanged Q4 2021 8 quarters
Unum Group 1.0% 4,778,110 235.0M USD −9.4% reduced Q1 2022 7 quarters
PGR Progressive Corporation 0.6% 1,145,322 159.5M USD +188.9% increased Q1 2022 7 quarters
MA Mastercard 0.5% 292,288 115.7M USD −71.1% reduced Q1 2022 7 quarters
Amylyx Pharmaceuticals Inc 0.2% 2,962,555 54.2M USD unchanged Q1 2022 7 quarters
MCK McKesson Corporation 2.6% 1,457,725 633.9M USD +178.1% increased Q2 2022 6 quarters
Pepgen Inc < 0.1% 1,482,434 7.5M USD unchanged Q2 2022 6 quarters
UNH UnitedHealth Group 3.8% 1,857,944 936.8M USD +3.5% increased Q3 2022 5 quarters
CDNS Cadence Design Systems 1.6% 1,653,230 387.4M USD −5.5% reduced Q3 2022 5 quarters
Valvoline Inc 1.2% 8,867,163 285.9M USD +15.4% increased Q3 2022 5 quarters
Trevi Therapeutics Inc < 0.1% 4,400,000 9.6M USD unchanged Q3 2022 5 quarters
FTNT Fortinet 1.7% 7,050,550 413.7M USD −8.3% reduced Q4 2022 4 quarters
CSX CSX Corporation 1.3% 10,640,828 327.2M USD −16.9% reduced Q4 2022 4 quarters
Kbr Inc 0.4% 1,555,209 91.7M USD +29.3% increased Q4 2022 4 quarters
Newamsterdam Pharma Company 0.3% 8,024,565 74.2M USD +23.0% increased Q4 2022 4 quarters
Farfetch Ltd < 0.1% 10,844,009 22.7M USD +127.4% increased Q4 2022 4 quarters
WDAY Workday, Inc. 4.6% 5,236,644 1.1B USD +72.3% increased Q1 2023 3 quarters
LULU Lululemon Athletica 1.2% 776,515 299.4M USD −34.7% reduced Q1 2023 3 quarters
SNPS Synopsys 0.6% 308,059 141.4M USD −0.8% reduced Q1 2023 3 quarters
CL Colgate-Palmolive 0.4% 1,424,845 101.3M USD +15.0% increased Q1 2023 3 quarters
Cnh Indl N V 0.3% 6,741,281 81.6M USD +41.4% increased Q1 2023 3 quarters
Coupang Inc 0.3% 4,362,544 74.2M USD −71.5% reduced Q1 2023 3 quarters
Zoominfo Technologies Inc 0.3% 3,754,192 61.6M USD +204.1% increased Q1 2023 3 quarters
Viking Therapeutics Inc 0.2% 4,573,316 50.6M USD +29.0% increased Q1 2023 3 quarters
UPS United Parcel Service 4.2% 6,660,484 1.0B USD +649.1% increased Q2 2023 2 quarters
DHR Danaher Corporation 4.2% 4,113,043 1.0B USD −3.4% reduced Q2 2023 2 quarters
PM Philip Morris International 2.3% 5,971,784 552.9M USD −34.1% reduced Q2 2023 2 quarters
PPG PPG Industries 2.1% 4,044,244 524.9M USD +349.4% increased Q2 2023 2 quarters
DASH DoorDash 1.7% 5,367,522 426.6M USD +98.8% increased Q2 2023 2 quarters
EG Everest Group 1.2% 808,459 300.5M USD −22.1% reduced Q2 2023 2 quarters
Epam Sys Inc 1.0% 918,497 234.9M USD +20.1% increased Q2 2023 2 quarters
FIVE9 Inc 0.9% 3,593,745 231.1M USD +65.6% increased Q2 2023 2 quarters
Gallagher Arthur J & Co 0.9% 957,820 218.3M USD +16.5% increased Q2 2023 2 quarters
CBRE CBRE Group 0.8% 2,504,799 185.0M USD −45.3% reduced Q2 2023 2 quarters
Tenet Healthcare Corp 0.3% 1,025,840 67.6M USD +182.0% increased Q2 2023 2 quarters
DDOG Datadog 0.2% 668,511 60.9M USD −24.0% reduced Q2 2023 2 quarters
Verastem Inc < 0.1% 2,456,292 20.0M USD +30.2% increased Q2 2023 2 quarters
XYZ Block, Inc. 2.2% 12,324,808 545.5M USD new Q3 2023 1 quarter
FCX Freeport-McMoRan 1.5% 9,769,679 364.3M USD new Q3 2023 1 quarter
ISRG Intuitive Surgical 0.8% 640,983 187.4M USD new Q3 2023 1 quarter
MET MetLife 0.8% 2,933,356 184.5M USD new Q3 2023 1 quarter
Rayzebio Inc 0.6% 6,642,700 147.5M USD new Q3 2023 1 quarter
DOV Dover Corporation 0.3% 536,587 74.9M USD new Q3 2023 1 quarter
KDP Keurig Dr Pepper 0.3% 2,288,261 72.2M USD new Q3 2023 1 quarter
BEKE KE Holdings 0.3% 4,620,000 71.7M USD new Q3 2023 1 quarter
Confluent Inc 0.2% 1,983,066 58.7M USD new Q3 2023 1 quarter
BSX Boston Scientific 0.2% 1,110,292 58.6M USD new Q3 2023 1 quarter
Mobileye Global Inc 0.2% 1,011,692 42.0M USD new Q3 2023 1 quarter
DG Dollar General 0.2% 368,172 39.0M USD new Q3 2023 1 quarter
Foot Locker Inc 0.2% 2,235,456 38.8M USD new Q3 2023 1 quarter
ARM Arm Holdings 0.1% 600,000 32.1M USD new Q3 2023 1 quarter
Maplebear Inc < 0.1% 125,000 3.7M USD new Q3 2023 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 77.2M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 111.5M USD 77.2M USD

Breakdown by sector

  • Financials 14.2%
  • Health Care 13.4%
  • Technology 12.6%
  • Industrials 12.0%
  • Consumer Discretionary 7.5%
  • Materials 4.2%
  • Communication Services 3.7%
  • Consumer Staples 3.1%
  • Real Estate 0.8%
  • not in our coverage 28.6%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close